Pfizer's Historic Drug Cost Agreement with U.S. Government
Pfizer Inc has entered a significant agreement with the U.S. government aimed at reducing drug costs for American patients. While specific terms are undisclosed, most primary care treatments and some specialty brands will see savings up to 85%, averaging at 50% cost reduction.
Pharmaceutical giant Pfizer Inc has officially announced a groundbreaking agreement with the U.S. government to slash drug costs for American patients. This initiative marks a major shift in healthcare affordability.
Though the specific terms of the agreement remain confidential, the impact is expected to be wide-reaching. A large majority of primary care treatments, alongside select specialty brands, will be offered at significant savings.
According to Pfizer, these savings will range as high as 85%, with an average reduction of 50%. This move is set to alleviate financial burdens on many Americans and reshape the landscape of drug pricing.
(With inputs from agencies.)
Advertisement
Google News